\
&
Contact us
\
&
Contact us
Published on | 4 years ago
ProgrammesAn expert group on the impact of the COVID-19 pandemic on gender equality in EU Research and Innovation will be established by the Directorate-General for Research and Innovation of the European Commission. A call for applications for members is currently open. The call is announced in the Horizon Europe work programme 2021-2022 Widening participation and strengthening the European Research Area (WIDERA p.154) and on the Register of European Commission Expert Groups and Other Similar Entities.
The task of the expert group is threefold:
The group will contain up to 15 members and a reserve list will be set up. Members will be appointed for one year, with the possibility of renewal. The deadline of the call for applications for members of the expert group is 2 December 2021 12:00 CET.
All information on the call, application and selection procedure can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
